<DOC>
	<DOCNO>NCT00699387</DOCNO>
	<brief_summary>Background : Chagas disease parasitic infection cause Trypanosome cruzi . The initial phase infection happen mainly child . Up 10 % infected child die . Survivors often develop chronic infection lead heart disease complication 30 % patient . These complication often result death severe handicap early adulthood , deprive society individual productive year . There 20 million people infected Latin America . Complications lead 20,000 death every year . Treatment acute phase benznidazole lead high cure rate . However , study drug virtually none child , even though benznidazole develop 30 year ago . Hypotheses Specific Aims : We hypothesize pharmacokinetics benznidazole child different adult , obtain information absorb , distribute eliminate child allow optimization treatment Chagas disease population . This turn improve outlook child reduce mortality long term complication . We aim study pharmacokinetics benznidazole child receive drug treatment Chagas disease , correlate treatment effectiveness incidence adverse effect . Potential Impact : This novel knowledge allow good rational approach treatment Chagas disease . It also set foundation study able test improve therapy may increase treatment response vulnerable child .</brief_summary>
	<brief_title>Population Pharmacokinetics Benznidazole Children With Chagas Disease</brief_title>
	<detailed_description />
	<mesh_term>Chagas Disease</mesh_term>
	<mesh_term>Benzonidazole</mesh_term>
	<criteria>Children 2 12 year old sex , diagnosis Chagas ' disease eligible treatment benznidazole , per current treatment protocol . Chagas disease diagnostic criterion : At least 2 positive serological test Trypanosoma cruzi infection ( ELISA , hemoagglutination , particle agglutination test ) . Informed consent sign parent , consent assent patient ( accord age consenting capacity ) . Patients history hypersensitivity benznidazole drug excipients Immunocompromised patient Altered hepatic function ( increase AST/ALT x3 bilirubin x3 ) alter renal function ( increase creatinine x3 ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Chagas disease</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>benznidazole</keyword>
	<keyword>population pharmacokinetics</keyword>
	<keyword>neglect disease</keyword>
	<keyword>parasitology</keyword>
	<keyword>pediatric clinical pharmacology</keyword>
</DOC>